Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01353521
Other study ID # CEUSEVCRC
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 2013
Est. completion date December 2022

Study information

Verified date December 2021
Source St. Joseph's Healthcare Hamilton
Contact Anil Kapoor, MD, FRCSC
Phone (905) 522-6536
Email akapoor@mcmaster.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Complex renal cysts are often incidentally detected on imaging. The differential diagnosis of the complex renal cyst includes various benign cystic lesions, which are based on the Bosniak classification scheme. Currently the standard of care in evaluating a complex renal cyst is using a contrast-enhanced computed tomography (CT) scan, or a contrast-enhanced magnetic resonance imaging (MRI) scan. Since both of these modalities present adverse events due to frequent high doses of radiation, a technique such as a contrast-enhanced ultrasound (CEUS) can be used to obtain the same results, without having to impose high doses of radiation upon a patient.


Description:

By evaluating complex renal cysts using a contrast-enhanced ultrasound (CEUS), it can be established as to whether or not the results are better, the same, or worse, when compared to CT and/or MRI scans.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date December 2022
Est. primary completion date December 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - at least 18 years old and capable of giving informed consent - all patients undergoing CT evaluation of complex renal cysts at our centre (either initially or in follow-up) - A complex renal cyst defined as Bosniak IIF, III or IV Exclusion Criteria: - pregnant patients - patients with contrast allergies - patients with non-cystic, solid renal masses - patients with simple cysts (Bosniak class I and II)

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Contrast-enhanced ultrasound
A contrast-enhanced ultrasound utilizes intravenous gas-filled microbubbles to enhance visualization in real time.

Locations

Country Name City State
Canada St. Joseph's Healthcare Hamilton Hamilton Ontario

Sponsors (2)

Lead Sponsor Collaborator
St. Joseph's Healthcare Hamilton McMaster University

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary concordance between CEUS and CT Complex renal cysts will be classified using the Bosniak classification system for both the CEUS and CT and compared. If surgical removal of a complex cyst is required (Bosniak IIF, III or IV), then the pathology will be evaluated with a single CEUS and a CT (The CEUS will be conducted 14 days within the CT). (Baseline, follow up at 3, 6, 9, & 12 months)
Secondary histopathological diagnosis after surgery of complex renal cysts Baseline and every three months until the end of study.
Secondary Average percent difference of CEUS vs CT imaging If during watchful waiting another CEUS is needed to be done in cases where a CT scan does show change at a follow up visit, then this average percent difference will also be calculated at this point. Baseline imaging (CEUS 14 days within a CT scan)
See also
  Status Clinical Trial Phase
Recruiting NCT04558593 - Surveillance of Complex Renal Cysts - The SOCRATIC Study